Jpmorgan Chase & CO Ensysce Biosciences, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.14 Trillion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$230.4 - $1140.0 $302,745 - $1.5 Million
-1,314 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$300.0 - $1228.8 $394,200 - $1.61 Million
1,314 New
1,314 $6,000

Others Institutions Holding ENSC

# of Institutions
1
Shares Held
100
Call Options Held
0
Put Options Held
0
View Full List

About Ensysce Biosciences, Inc.

ENSC Quotes by TradingView
  • Ticker ENSC
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,918,900
  • Market Cap $1.25M
  • Description
  • Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abu...
More about ENSC
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email